Leerink Swann also believes that the Zytiga patent will expire in 2016: http://www.streetinsider.com/Analyst+Comments/Leerink+Swann+Increases+Numbers+on+Medivation+(MDVN)+Based+on+AFFIRM+Results+and+Physician+Feedback/7138435.html